A detailed history of Lazard Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lazard Asset Management LLC holds 679,475 shares of BMY stock, worth $39.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
679,475
Previous 1,686,282 59.71%
Holding current value
$39.2 Million
Previous $70 Million 49.79%
% of portfolio
0.05%
Previous 0.1%

Shares

45 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $39.9 Million - $52.1 Million
-1,006,807 Reduced 59.71%
679,475 $35.2 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $1.81 Million - $2.38 Million
-44,973 Reduced 2.6%
1,686,282 $70 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $28.3 Million - $32 Million
588,799 Added 51.54%
1,731,255 $93.9 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $9.63 Million - $11.5 Million
198,701 Added 21.05%
1,142,456 $58.6 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $3.37 Million - $3.76 Million
-58,150 Reduced 5.8%
943,755 $54.8 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $3.96 Million - $4.39 Million
62,108 Added 6.61%
1,001,905 $64.1 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $730,498 - $828,550
-11,117 Reduced 1.17%
939,797 $65.1 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $2.37 Million - $2.81 Million
34,636 Added 3.78%
950,914 $68.4 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $26,200 - $15.5 Million
201,542 Added 28.2%
916,278 $65.1 Million
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $7.1 Million - $7.82 Million
97,765 Added 15.85%
714,736 $55 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $55,885 - $67,011
-909 Reduced 0.15%
616,971 $45.1 Million
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $6.79 Million - $7.91 Million
-126,558 Reduced 17.0%
617,880 $38.5 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $4.85 Million - $5.68 Million
-82,000 Reduced 9.92%
744,438 $44 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $15.1 Million - $16.5 Million
-244,138 Reduced 22.8%
826,438 $55.2 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $9 Million - $10.1 Million
-151,599 Reduced 12.4%
1,070,576 $67.6 Million
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $6.23 Million - $7.06 Million
-107,883 Reduced 8.11%
1,222,175 $75.8 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $1.63 Million - $1.81 Million
28,421 Added 2.18%
1,330,058 $80.2 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $1.92 Million - $2.24 Million
35,001 Added 2.76%
1,301,637 $76.5 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $8.97 Million - $13 Million
-193,297 Reduced 13.24%
1,266,636 $70.6 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $10.2 Million - $13.3 Million
207,050 Added 16.53%
1,459,933 $93.7 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $2.16 Million - $2.57 Million
-50,597 Reduced 3.88%
1,252,883 $63.5 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $4.57 Million - $5.06 Million
102,511 Added 8.54%
1,303,480 $59.1 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $17.7 Million - $21.1 Million
391,918 Added 48.44%
1,200,969 $57.3 Million
Q4 2018

Aug 28, 2019

SELL
$48.76 - $63.23 $90,937 - $117,923
-1,865 Reduced 0.23%
809,051 $42.1 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $5.49 Million - $7.12 Million
-112,656 Reduced 12.2%
810,916 $42.1 Million
Q3 2018

Aug 30, 2019

SELL
$55.19 - $62.25 $115,954 - $130,787
-2,101 Reduced 0.23%
923,572 $57.3 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $8.47 Million - $9.55 Million
-153,464 Reduced 14.22%
925,673 $57.5 Million
Q2 2018

Aug 30, 2019

SELL
$50.53 - $62.98 $106,163 - $132,320
-2,101 Reduced 0.19%
1,079,137 $59.7 Million
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $2.45 Million - $3.06 Million
48,542 Added 4.7%
1,081,238 $59.8 Million
Q1 2018

Aug 28, 2019

SELL
$59.92 - $68.98 $125,891 - $144,926
-2,101 Reduced 0.2%
1,032,696 $65.3 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $3.94 Million - $4.53 Million
-65,728 Reduced 5.97%
1,034,797 $65.4 Million
Q4 2017

Aug 28, 2019

SELL
$59.94 - $65.35 $95,184 - $103,775
-1,588 Reduced 0.14%
1,100,525 $67.4 Million
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $14.5 Million - $15.8 Million
241,228 Added 28.02%
1,102,113 $67.5 Million
Q3 2017

Aug 19, 2019

SELL
$55.23 - $63.74 $3,424 - $3,951
-62 Reduced 0.01%
860,885 $54.9 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $7.26 Million - $8.38 Million
131,490 Added 18.03%
860,947 $54.9 Million
Q2 2017

Aug 19, 2019

SELL
N/A
-202,504 Reduced 21.73%
729,457 $40.6 Million
Q1 2017

Aug 13, 2019

SELL
N/A
-754,297 Reduced 44.73%
931,961 $50.7 Million
Q4 2016

Jul 30, 2019

SELL
N/A
-562,716 Reduced 25.02%
1,686,258 $98.5 Million
Q3 2016

Aug 07, 2019

SELL
N/A
-206,128 Reduced 8.4%
2,248,974 $121 Million
Q2 2016

Jul 29, 2019

SELL
N/A
-194,721 Reduced 7.35%
2,455,102 $181 Million
Q1 2016

Jul 25, 2019

SELL
N/A
-59,591 Reduced 2.2%
2,649,823 $169 Million
Q4 2015

Jul 24, 2019

SELL
N/A
-451,110 Reduced 14.27%
2,709,414 $186 Million
Q3 2015

Jul 15, 2019

SELL
N/A
-1,147,183 Reduced 26.63%
3,160,524 $187 Million
Q2 2015

Jul 08, 2019

SELL
N/A
-371,304 Reduced 7.94%
4,307,707 $287 Million
Q4 2014

Aug 29, 2019

BUY
N/A
4,679,011
4,679,011 $276 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.